tiprankstipranks
Ocuphire Pharma (OCUP)
NASDAQ:OCUP

Ocuphire Pharma (OCUP) Financial Statements

885 Followers

Ocuphire Pharma Financial Overview

Ocuphire Pharma's market cap is currently ―. The company's EPS TTM is $-0.473; its P/E ratio is -4.27; Ocuphire Pharma is scheduled to report earnings on May 3, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 1.69M$ 11.94M$ 3.67M$ 1.75M$ 39.85M
Gross Profit$ 1.69M$ 11.94M$ 3.67M$ 1.75M$ 39.85M
EBIT$ -4.80M$ 5.58M$ -4.96M$ -5.79M$ 34.26M
EBITDA$ -4.79M$ 5.58M-$ -5.79M$ 34.26M
Net Income Common Stockholders$ -6.12M$ 6.89M$ -4.96M$ -5.79M$ 33.94M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 50.52M$ 42.41M$ 40.02M$ 39.02M$ 42.65M
Total Assets$ 53.95M$ 54.19M$ 43.49M$ 45.45M$ 48.99M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -50.52M$ -42.41M$ -40.02M$ -39.02M$ -42.65M
Total Liabilities$ 4.04M$ 3.91M$ 5.76M$ 4.15M$ 2.75M
Stockholders Equity$ 49.91M$ 50.28M$ 37.70M$ 41.25M$ 46.24M
Cash Flow-
Free Cash Flow$ 4.55M$ -3.00M-$ -3.65M$ 28.79M
Operating Cash Flow$ 4.55M$ -3.00M-$ -3.65M$ 28.79M
Investing Cash Flow-----
Financing Cash Flow$ 3.60M$ 5.38M--$ -12.00K
Currency in USD

Ocuphire Pharma Earnings and Revenue History

Ocuphire Pharma Debt to Assets

Ocuphire Pharma Cash Flow

Ocuphire Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis